Clinical Trial of a Hydrophilic EMV Toric Lens RAO210T in the Correction of Aphakia and Corneal Astigmatism
Clinical Trial to Investigate the Safety and Effectiveness of a Hydrophilic EMV Toric Lens RAO210T in the Correction of Aphakia and Post-operative Corneal Astigmatism
Sponsor: Rayner Intraocular Lenses Limited
A NA clinical study on Cataract and Corneal Astigmatism, this trial is completed. The trial is conducted by Rayner Intraocular Lenses Limited and has accumulated 8 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Feb 2026 — Present [monthly]
Completed NA
Status: Withheld → Completed · Phase: None → NA
-
Mar 2025 — Feb 2026 [monthly]
Withheld
-
Nov 2024 — Mar 2025 [monthly]
Withheld
-
Oct 2024 — Nov 2024 [monthly]
Withheld
-
Sep 2024 — Oct 2024 [monthly]
Withheld
▶ Show 3 earlier versions
-
Feb 2024 — Sep 2024 [monthly]
Withheld
-
Nov 2023 — Feb 2024 [monthly]
Withheld
-
Sep 2023 — Nov 2023 [monthly]
Withheld
First recorded
Aug 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rayner Intraocular Lenses Limited
For direct contact, visit the study record on ClinicalTrials.gov .